knowledge -WSS

knowledge

author：hotspot 2025-09-30 18:54:49 - browse：34292

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Wikipedia

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Illumina slashes 2023 revenue projections yet again

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

SCOTUS questions limit to govt efforts to fight misinformation

Bird flu researchers hone in on Finland’s mink farms

Physicians and social media: If you see something, say something?

Wikipedia

knowledge

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Creating egg and sperm cells from stem cells raises ethical issues

The cancer drug shortage isn’t new — and neither are the solutions

Methadone treatment changes are coming. Do they go far enough?

After affirmative action ruling, medical educators look to 'holistic review'

Idaho college killings prosecutors challenge defense's grand jury claims

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Baby aspirin cuts fat buildup in liver disease patients, in small study

Activists slam private health insurers over coverage restrictions

Neuroscience’s long legacy of racism

knowledge

Hospitals are dialing back on venture capital investing

BMS, looking to build heart drug business, turns to AI for diagnosis

Idaho college killings prosecutors challenge defense's grand jury claims

Surge in Apellis stock fueled by confidence in safety of its eye drug

Stop the failed accountable care organization experiment

Plastic surgeons increase patient psychiatric screenings

Wikipedia

leisure time

hotspot

hotspot